Published Guidance, NICE advice and quality standards

Skip to filters Skip to results

Showing 11 to 20 of 465

Sort by

Last updated date between 1/1/2000 and 31/10/2017Remove Last updated date between 1/1/2000 and 31/10/2017 filter
Type: GuidanceRemove Type: Guidance filter
Type: Quality standardRemove Type: Quality standard filter
Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter
Guidance programme: Clinical guidelinesRemove Guidance programme: Clinical guidelines filter
Guidance programme: Public health guidelinesRemove Guidance programme: Public health guidelines filter
Guidance programme: Diagnostics guidanceRemove Guidance programme: Diagnostics guidance filter
Guidance programme: Medical technologies guidanceRemove Guidance programme: Medical technologies guidance filter
Guidance programme: Cancer service guidelinesRemove Guidance programme: Cancer service guidelines filter
Guidance programme: Medicines practice guidelinesRemove Guidance programme: Medicines practice guidelines filter
Guidance programme: Highly specialised technologies guidanceRemove Guidance programme: Highly specialised technologies guidance filter
Guidance programme: Safe staffing guidelinesRemove Guidance programme: Safe staffing guidelines filter
Guidance programme: Antimicrobial prescribing guidelinesRemove Guidance programme: Antimicrobial prescribing guidelines filter

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Reslizumab for treating severe eosinophilic asthma	TA479	4 October 2017	4 October 2017
Faltering growth: recognition and management of faltering growth in children	NG75	27 September 2017	27 September 2017
Cetuximab and panitumumab for previously untreated metastatic colorectal cancer	TA439	29 March 2017	25 September 2017
Type 2 diabetes: prevention in people at high risk	PH38	12 July 2012	15 September 2017
Pembrolizumab for advanced melanoma not previously treated with ipilimumab	TA366	25 November 2015	12 September 2017
Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapy	TA428	11 January 2017	12 September 2017
Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab	TA357	7 October 2015	12 September 2017
Fertility problems: assessment and treatment	CG156	20 February 2013	6 September 2017
Sorafenib for treating advanced hepatocellular carcinoma	TA474	6 September 2017	6 September 2017
Dimethyl fumarate for treating moderate to severe plaque psoriasis	TA475	6 September 2017	6 September 2017

Results per page

10
25
50
All